Valve repair is the preferred treatment in paediatric patients with valvular heart disease. However, replacement is sometimes unavoidable.
In young patients, the use of a mechanical prosthesis is favoured to avoid reoperations for premature structural degeneration of the valve.
However, mechanical valve replacement in a paediatric population is limited by small cardiac dimensions and the need for lifelong oral anticoagulation.
Limited long-term data is available, especially regarding INR management and valve-related events. 
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